Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity.
An AI algorithm based only on routine mammogram images plus age can predict a woman’s risk of major cardiovascular disease as well as standard risk assessment methods, finds research published online in the journal Heart.
Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help researchers—even those unfamiliar with gene editing—generate designs, analyze data and troubleshoot design flaws.
BrainsWay (Nasdaq:BWAY) today announced the FDA granted expanded clearance for its Deep Transcranial Magnetic Stimulation system to include an accelerated treatment protocol for major depressive disorder and patients with comorbid anxiety symptoms.
MicroPort CardioFlow said its Alwide Plus balloon catheter has received CE mark approval, clearing the company to market the device in Europe.
Roche announced today that it received CE mark for the integration of its Accu-Chek SmartGuide CGM with the mySugr app.
SMITHFIELD, R.I., Sept. 16, 2025 /PRNewswire/ — ALCOR Scientific today announced a breakthrough in erythrocyte sedimentation rate (ESR) testing that solves one of the most persistent challenges facing modern laboratories: limited blood sample stability.
REVIVO™ Dual Summit features a fusion of ablative, sub-ablative and non-ablative energy treatments with increased power and a larger spot size, pushing the limits for superior results and faster recovery.
BETHLEHEM, Pa., Sept. 15, 2025 /PRNewswire/ — B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced today the launch of its new Tromethamine Injection in the EXCEL® IV Container 500 mL in the U.S. market. This addition enhances the company’s ability to serve the diverse needs of providers and their patients.
A team of University of Saskatchewan (USask) researchers have identified a pathway to help the human body defend itself against sepsis—a life-threatening condition caused by the body’s inappropriate response to an infection.